Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bortezomib and Pemetrexed in Advanced Solid Tumors and NSCLC
NCT00389805Phase 2Completed
- Sponsor
- University of California, Davis
- Start
- Mar 2005
- Primary completion
- Dec 2006
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of bortezomib in non-small cell lung cancer (NSCLC), solid tumor, sponsored by University of California, Davis. Started Mar 2005; status: completed.
02
Drugs
bortezomib
03
Conditions
non-small cell lung cancer (NSCLC)solid tumor
Beyond the preview
Go deeper on NCT00389805.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00389805.